Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.sanofiindialtd.com | |
Market Cap | 12,475.34 Cr. | |
Enterprise Value(EV) | 11,776.34 Cr. | 2022-06 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 251.88 | Trailing Twelve Months Ending 2022-09 |
Price-Earning Ratio (PE) | 21.51 | Trailing Twelve Months Ending 2022-09 |
Industry PE | 32.44 | Trailing Twelve Months Ending 2022-09 |
Book Value / Share | 688.49 | Trailing Twelve Months Ending 2022-09 |
Price to Book Value | 7.87 | Calculated using Price: 5,416.85 |
Dividend Yield | 9.05 | Period Ending 2021-12 |
No. of Shares Subscribed | 2.30 Cr. | 23,030,622 Shares |
FaceValue | 10 | |
Company Profile | ||
The company is dedicated to supporting people through their health challenges. It is a global biopharmaceutical company focused on human health. The company prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. The company stand by the few who suffer from rare diseases and the millions with long-term chronic conditions. |
1 Day |
|
-0.60% |
1 Week |
|
-3.85% |
1 Month |
|
-7.35% |
3 Month |
|
-3.99% |
6 Month |
|
-17.34% |
1 Year |
|
-28.14% |
2 Year |
|
-31.50% |
5 Year |
|
+8.76% |
10 Year |
|
+135.05% |
9 years | 2013-12 | 2014-12 | 2015-12 | 2016-12 | 2017-12 | 2018-12 | 2019-12 | 2020-12 | 2021-12 | |
Return on Equity (%) | 20.97 | 18.70 | 20.68 | 17.43 | 16.87 | 18.18 | 18.07 | 21.39 | 44.65 | |
Return on Capital Employed (%) | 30.75 | 26.47 | 30.96 | 27.51 | 26.38 | 28.76 | 25.75 | 29.77 | 57.98 | |
Return on Assets (%) | 15.11 | 12.84 | 13.88 | 12.30 | 9.50 | 8.37 | 8.28 | 9.24 | 17.74 |
Particulars | 10 years | 2013-12 Rs. Cr. | 2014-12 Rs. Cr. | 2015-12 Rs. Cr. | 2016-12 Rs. Cr. | 2017-12 Rs. Cr. | 2018-12 Rs. Cr. | 2019-12 Rs. Cr. | 2020-12 Rs. Cr. | 2021-12 Rs. Cr. | 2022-06* Rs. Cr. |
Shh. Funds | 1,347 | 1,486 | 1,627 | 1,883 | 2,026 | 2,219 | 2,442 | 2,119 | 2,226 | 1,455 | |
Non Curr. Liab. | 63 | 86 | 161 | 156 | 1,335 | 1,357 | 1,124 | 1,280 | 1,039 | 72 | |
Curr. Liab. | 469 | 656 | 617 | 502 | 962 | 1,193 | 1,674 | 1,694 | 2,291 | 650 | |
Minority Int. | |||||||||||
Equity & Liab. | 1,878 | 2,228 | 2,405 | 2,541 | 4,324 | 4,769 | 5,240 | 5,093 | 5,555 | 2,177 | |
Non Curr. Assets | 931 | 965 | 1,161 | 966 | 2,519 | 2,608 | 2,141 | 2,253 | 1,876 | 466 | |
Curr. Assets | 947 | 1,263 | 1,244 | 1,575 | 1,805 | 2,162 | 3,099 | 2,841 | 3,679 | 1,710 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 1,878 | 2,228 | 2,405 | 2,541 | 4,324 | 4,769 | 5,240 | 5,093 | 5,555 | 2,177 |
Particulars | 10 years | 2013-12 Rs. Cr. | 2014-12 Rs. Cr. | 2015-12 Rs. Cr. | 2016-12 Rs. Cr. | 2017-12 Rs. Cr. | 2018-12 Rs. Cr. | 2019-12 Rs. Cr. | 2020-12 Rs. Cr. | 2021-12 Rs. Cr. | 2022-09 Rs. Cr. TTM |
Net Sales | 1,809 | 1,977 | 2,193 | 2,367 | 2,464 | 2,771 | 3,071 | 2,902 | 2,957 | 2,786 | |
Other Income | 58 | 64 | 51 | 66 | 81 | 90 | 94 | 90 | 75 | 68 | |
Total Income | 1,867 | 2,042 | 2,245 | 2,433 | 2,544 | 2,861 | 3,165 | 2,992 | 3,031 | 2,854 | |
Total Expenditure | -1,411 | -1,639 | -1,734 | -1,832 | -1,926 | -2,148 | -2,405 | -2,189 | -2,194 | -2,121 | |
PBIDT | 456 | 403 | 511 | 602 | 618 | 713 | 759 | 803 | 837 | 733 | |
Interest | 0 | 0 | 0 | -2 | -1 | -1 | 0 | -2 | -2 | -2 | |
Depreciation | -92 | -97 | -113 | -119 | -102 | -103 | -100 | -82 | -67 | -43 | |
Taxation | -123 | -109 | -159 | -176 | -189 | -229 | -186 | -200 | -313 | -226 | |
Exceptional Items | 25 | 67 | 84 | -59 | -42 | 489 | 118 | ||||
PAT | 265 | 264 | 322 | 304 | 326 | 381 | 414 | 478 | 944 | 580 | |
Adjusted EPS | 115 | 114 | 140 | 132 | 142 | 165 | 180 | 208 | 411 | 252 |
Particulars | 10 years | 2012-12 Rs. Cr. | 2013-12 Rs. Cr. | 2014-12 Rs. Cr. | 2015-12 Rs. Cr. | 2016-12 Rs. Cr. | 2017-12 Rs. Cr. | 2018-12 Rs. Cr. | 2019-12 Rs. Cr. | 2020-12 Rs. Cr. | 2021-12 Rs. Cr. |
Cash Fr. Operatn. | 290 | 273 | 265 | 213 | 322 | 435 | 374 | 412 | 611 | 559 | |
Cash Fr. Inv. | -5 | -335 | 61 | 36 | -155 | -79 | -73 | 66 | 276 | 631 | |
Cash Fr. Finan. | -90 | -105 | -122 | -147 | -180 | -188 | -197 | -183 | -810 | -849 | |
Net Change | 195 | -168 | 205 | 102 | -13 | 168 | 104 | 295 | 78 | 341 | |
Cash & Cash Eqvt | 429 | 261 | 466 | 568 | 554 | 722 | 825 | 1,120 | 1,197 | 1,538 |
Fri, 27 Jan 2023
Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Year Ended 31St December 2022 Pursuant to Regulation 40 (9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we enclose herewith Certificate of M/s. Makarand M. Joshi & Co. Company Secretaries for the year ended 31st December 2022 |
Fri, 20 Jan 2023
Compliance Certificate For The Year Ended 31St December 2022 As required under Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby confirm that activities in relation to both physical and electronic share transfer facility were maintained by the Companys Registrar and Share Transfer Agent viz. Link Intime India Private Limited which is registered as Registrar & Share Transfer Agent in Category - I with SEBI vide Registration Number : INR000004058 for the year ended 31st December 2022. |
Mon, 09 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Link Intime India Private Limited Registrar and Share Transfer Agent (RTA) of the Company has provided the enclosed certificate for the year ended 31st December 2022 under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018. |
Thu, 02 Feb 2023 |
|
|
|
|
|